Literature DB >> 10704149

Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines.

V Desplat1, C Dulery, V Praloran, Y Denizot.   

Abstract

The objectives of this work are to investigate the incorporation of arachidonic acid (AA) in the human myeloma cell lines OPM2, U266 and IM9, and to assess the effect of AA and lipoxygenase products of AA on their growth. The kinetics of acylation of [3H]AA indicates that myeloma cells incorporate AA into their membrane phospholipids and triglycerides. PLA2-treatment and base hydrolysis experiments confirm that [3H]AA is incorporated unmodified in U266, IM9 and OPM2 phospholipids, and is linked by an ester bond. Prelabeling-chase experiments indicate no trafficking of labeled AA among the various phospholipid species. Addition of AA and lipoxygenase products of AA (leukotriene B4 and C4, lipoxin A4 and B4, 12- and 15-hydroxyeicosatetraenoic acid) have no effect on U266, IM9 and OPM2 proliferation assessed by [3H]thymidine incorporation into DNA. In conclusion, while human myeloma cells readily incorporate AA in their membrane phospholipids and triglycerides, AA and lipoxygenase products are not important modulators of their proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704149      PMCID: PMC1781787          DOI: 10.1080/09629359990612

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

1.  The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition.

Authors:  B N Setty; J E Graeber; M J Stuart
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

Review 2.  Phospholipid fatty acid remodeling in mammalian cells.

Authors:  J I MacDonald; H Sprecher
Journal:  Biochim Biophys Acta       Date:  1991-07-09

3.  Lipoxygenase inhibitors enhance the proliferation of human B cells.

Authors:  T W Behrens; L G Lum; E A Lianos; J S Goodwin
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

4.  Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines.

Authors:  D S Snyder; R Castro; J F Desforges
Journal:  Exp Hematol       Date:  1989-01       Impact factor: 3.084

Review 5.  Control of arachidonate levels within inflammatory cells.

Authors:  F H Chilton; A N Fonteh; M E Surette; M Triggiani; J D Winkler
Journal:  Biochim Biophys Acta       Date:  1996-01-05

6.  Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages.

Authors:  M Triggiani; A Oriente; G Marone
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

7.  Mobilization of different arachidonate pools and their roles in the generation of leukotrienes and free arachidonic acid during immunologic activation of mast cells.

Authors:  A N Fonteh; F H Chilton
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

8.  Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.

Authors:  F Ondrey; J E Harris; K M Anderson
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

9.  Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines.

Authors:  T Tsukada; K Nakashima; S Shirakawa
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

10.  Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures.

Authors:  V Desplat; F Dupuis; F Trimoreau; C Dulery; V Praloran; Y Denizot
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more
  1 in total

1.  Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.

Authors:  Ellen Ackerstaff; Barjor Gimi; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.